ICU Medical, Inc. (ICUI) Stock Score, Valuation & Financial Research
ICU Medical, Inc. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 20/100.
Quick answer for ICUI
ICU Medical, Inc. currently has a Wall Street Score of 20/100. The stored market price is $156.48. Its financial score is 12/100. Its valuation score is 0/100. The latest WSS change is -1.0 points. These figures are a research snapshot, not a buy or sell recommendation.
What ICU Medical, Inc. does
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common fo
ICUI financial snapshot
- Wall Street Score:
- 20/100
- Current price:
- $156.48
- Market capitalization:
- $3.91B
- Revenue:
- $2.16B
- Net income:
- $30.1M
- Free cash flow:
- $91.8M
- Cash:
- $298.3M
- Total debt:
- $1.27B
- EPS:
- 0.03
- P/E ratio:
- 5268.7x
- Financial score:
- 12/100
- Valuation score:
- 0/100
- Revenue score:
- 6/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $91.8M, showing positive cash generation.
- The balance sheet shows $298.3M of cash versus $1.27B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is -1.0 points: ICUI decreased 1 points because Asset declined by 3.4 points, Capital declined by 2 points, Management declined by 3.1 points.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 12/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-08-14.
How to research ICUI
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.